BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zeng QL, Zhang JY, Zhang Z, Wang LF, Wang FS. Sofosbuvir and ABT-450: Terminator of hepatitis C virus? World J Gastroenterol 2013; 19(21): 3199-3206 [PMID: 23745021 DOI: 10.3748/wjg.v19.i21.3199] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Abdeen AM, Essawy T, Mohammed SS. Effect of Sofosbuvir Administration and Its Withdrawal on the Submandibular Salivary Gland of Adult Male Albino Rats: A Histological and Ultra-Structural Study. Open Access Maced J Med Sci 2019;7:4101-9. [PMID: 32165960 DOI: 10.3889/oamjms.2019.868] [Reference Citation Analysis]
2 Lee YM, Duh Y, Wang ST, Lai MM, Yuan HS, Lim C. Using an Old Drug to Target a New Drug Site: Application of Disulfiram to Target the Zn-Site in HCV NS5A Protein. J Am Chem Soc 2016;138:3856-62. [PMID: 26928525 DOI: 10.1021/jacs.6b00299] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
3 Abdallah F, Mohamed G, Ibrahim M, El Tarabily M. Effectiveness of Sofosbuvir, Ribavirin and PEG-IFNα-2a in the Treatment of Naïve Egyptian Patients With Chronic Hepatitis C Virus Genotype 4. Am J Med Sci 2018;355:456-66. [PMID: 29753376 DOI: 10.1016/j.amjms.2017.12.016] [Reference Citation Analysis]
4 Saleem K, Wahid B, Ali A, Rafique S, Naz Z, Usman S, Idrees M. Unexpected Response Profiles Seen in Hepatitis C Virus-Infected Patients Treated with Sofosbuvir Plus Ribavirin: Five Case Reports. Viral Immunol 2018;31:480-3. [PMID: 29694794 DOI: 10.1089/vim.2017.0199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Kulkarni AS, Damha MJ, Schinazi RF, Mo H, Doehle B, Sagan SM, Götte M. A Complex Network of Interactions between S282 and G283 of Hepatitis C Virus Nonstructural Protein 5B and the Template Strand Affects Susceptibility to Sofosbuvir and Ribavirin. Antimicrob Agents Chemother 2016;60:2018-27. [PMID: 26824949 DOI: 10.1128/AAC.02436-15] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
6 Carrion AF, Gutierrez J, Martin P. New antiviral agents for the treatment of hepatitis C: ABT-450. Expert Opin Pharmacother. 2014;15:711-716. [PMID: 24517400 DOI: 10.1517/14656566.2014.889116] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
7 Bakulin I, Pasechnikov V, Varlamicheva A, Sannikova I. NS3 protease inhibitors for treatment of chronic hepatitis C: Efficacy and safety. World J Hepatol 2014; 6(5): 326-339 [PMID: 24868326 DOI: 10.4254/wjh.v6.i5.326] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
8 Ruiz Ramos J, Romero Hernández I, Marrero Álvarez P, Marqués Miñana MR, Fernández Megía MJ, Poveda Andrés JL. [Experience in the management of immunosuppressant treatment with hepatitis C virus protease inhibitors]. Gastroenterol Hepatol 2014;37:558-63. [PMID: 24951300 DOI: 10.1016/j.gastrohep.2014.05.004] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Yang HJ, Ryoo JY, Yoo BK. Meta-analysis of the efficacy and safety of sofosbuvir for the treatment of hepatitis C virus infection. Int J Clin Pharm. 2015;37:698-708. [PMID: 26047942 DOI: 10.1007/s11096-015-0144-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
10 Chung DH, Golden JE, Adcock RS, Schroeder CE, Chu YK, Sotsky JB, Cramer DE, Chilton PM, Song C, Anantpadma M, Davey RA, Prodhan AI, Yin X, Zhang X. Discovery of a Broad-Spectrum Antiviral Compound That Inhibits Pyrimidine Biosynthesis and Establishes a Type 1 Interferon-Independent Antiviral State. Antimicrob Agents Chemother 2016;60:4552-62. [PMID: 27185801 DOI: 10.1128/AAC.00282-16] [Cited by in Crossref: 36] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
11 Chen Y, Wang S, Yi Z, Tian H, Aliyari R, Li Y, Chen G, Liu P, Zhong J, Chen X. Interferon-inducible cholesterol-25-hydroxylase inhibits hepatitis C virus replication via distinct mechanisms. Sci Rep. 2014;4:7242. [PMID: 25467815 DOI: 10.1038/srep07242] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 7.4] [Reference Citation Analysis]
12 Zeng QL, Xu GH, Zhang JY, Li W, Zhang DW, Li ZQ, Liang HX, Li CX, Yu ZJ. Generic ledipasvir-sofosbuvir for patients with chronic hepatitis C: A real-life observational study. J Hepatol 2017;66:1123-9. [PMID: 28189754 DOI: 10.1016/j.jhep.2017.01.025] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
13 Tao T, Jiang X, Chen Y, Song Y. Efficacy and Safety of Ledipasvir/Sofosbuvir with and without Ribavirin in Patients with Chronic Hepatitis C Virus Genotype 1 Infection: a meta-analysis. Int J Infect Dis 2017;55:56-71. [PMID: 28040553 DOI: 10.1016/j.ijid.2016.12.023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
14 Zeng QL, Li ZQ, Liang HX, Xu GH, Li CX, Zhang DW, Li W, Sun CY, Wang FS, Yu ZJ. Unexpected high incidence of hepatocellular carcinoma in patients with hepatitis C in the era of DAAs: Too alarming? J Hepatol. 2016;65:1068-1069. [PMID: 27476763 DOI: 10.1016/j.jhep.2016.07.029] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
15 Posthuma CC, Te Velthuis AJW, Snijder EJ. Nidovirus RNA polymerases: Complex enzymes handling exceptional RNA genomes. Virus Res 2017;234:58-73. [PMID: 28174054 DOI: 10.1016/j.virusres.2017.01.023] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 12.4] [Reference Citation Analysis]
16 Bhatia HK, Singh H, Grewal N, Natt NK. Sofosbuvir: A novel treatment option for chronic hepatitis C infection. J Pharmacol Pharmacother. 2014;5:278-284. [PMID: 25422576 DOI: 10.4103/0976-500x.142464] [Cited by in Crossref: 87] [Cited by in F6Publishing: 38] [Article Influence: 10.9] [Reference Citation Analysis]